John Vavricka Atea Pharmaceuticals, Inc. (AVIR) insider trading activity
John Vavricka is Chief Commercial Officer of Atea Pharmaceuticals, Inc.. Currently has a direct ownership of 21,515 shares of AVIR, which is worth approximately $68,632. The most recent transaction as insider was on Feb 01, 2024, when has been sold 11,819 shares (Common Stock) at a price of $3.84 per share, resulting in proceeds of $45,384. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
21.5K
0%
3M change
n/a
12M change
Total Value Held
$68,632
JV
John Vavricka
Chief Commercial Officer
Boston, MA